Pericardial fat in type 2 diabetes: not just a biomarker, but a promising treatment target?

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Nafakhi H, Al-Mosawi AA, Mudhafar MM (2019) Pericardial fat versus BMI in the assessment of coronary atherosclerotic burden in patients with diabetes mellitus. Acta Diabetol. https://doi.org/10.1007/s00592-019-01465-9

    Article  PubMed  Google Scholar 

  2. 2.

    Zsóri G, Illés D, Ivány E et al (2019) In new-onset diabetes mellitus, metformin reduces fat accumulation in the liver, but not in the pancreas or pericardium. Metab Syndr Relat Disord 17(5):289–295

    Article  Google Scholar 

  3. 3.

    Jonker JT, Lamb HJ, van der Meer RW et al (2010) Pioglitazone compared with metformin increases pericardial fat volume in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 95(1):456–460

    CAS  Article  Google Scholar 

  4. 4.

    Hsu JC, Wang CY, Su MM, Lin LY, Yang WS (2019) Effect of empagliflozin on cardiac function, adiposity, and diffuse fibrosis in patients with type 2 diabetes mellitus. Sci Rep 9(1):1534

    Article  Google Scholar 

  5. 5.

    Christensen RH, von Scholten BJ, Hansen CS et al (2019) Epicardial adipose tissue predicts incident cardiovascular disease and mortality in patients with type 2 diabetes. Cardiovasc Diabetol 18(1):114

    Article  Google Scholar 

Download references

Funding

None.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Dimitrios Patoulias.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

Not required for this type of manuscript.

Human and animal rights

This manuscript does not contain any human or animal studies performed by any of the authors.

Informed consent

For this type of study, formal consent was not necessary.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Managed by Massimo Porta.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Patoulias, D., Papadopoulos, C. & Doumas, M. Pericardial fat in type 2 diabetes: not just a biomarker, but a promising treatment target?. Acta Diabetol 57, 905–906 (2020). https://doi.org/10.1007/s00592-020-01478-9

Download citation